期刊文献+

预防接种百白破﹙无细胞﹚疫苗后不良反应观察 被引量:1

下载PDF
导出
摘要 目的:观察接种百白破(无细胞)疫苗的不良反应及预防。方法资料随机选取正阳县疾病预防控制中心预防接种门诊2011年11月-2012年11月接种百白破(无细胞)疫苗的112例身体健康幼儿;给予112例幼儿全部接种百白破(无细胞)疫苗,观察其接种后不良反应情况。结果接种百白破(无细胞)疫苗主要不良反应为局部总不良反应47.32%,全身总不良反应27.67%,发热总不良反应70.53%,过敏总不良反应9.82%。结论充分了解接种百白破(无细胞)疫苗后不良反应,有利于提高其临床防控有效率,具有百白破(无细胞)疫苗准确接种指导意义。
作者 纪付仓
出处 《中国实用医药》 2014年第17期174-175,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献35

  • 1王志彬.接种无细胞百白破联合疫苗异常反应调查.国际生物制品学杂志,2008,31(2):90-91.
  • 2de Melker HE, Schellekens JF, Neppelenbroek SE, et al. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis,2000, 6(4) : 348-357.
  • 3StanleyAP.WalterAO.疫苗学.梁晓峰,罗凤基,封多佳,译.5版.北京:人民卫生出版社,2011:1193-1195.
  • 4Decker MD, Edwards KM, Bradley R, et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr, 1992, 120(2 Pt 1 ):184-189.
  • 5Shinefield H, Black S, Thear M, et al. 3atety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus- acellular pertussis vaccines. Pediatr Infect Dis J, 2006, 25 (4) : 287-292.
  • 6Mawas F, Dickinson R, Douglas-Bardsley A, et al. Immune interaction between components of acellular pertussis-diphtheria- tetanus (DTaP) vaccine and haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine, 2006, 24 ( 17 ) : 3505-3512.
  • 7Eskola J, Ward J, Dagan R, et al. Combined vaccination of haemophilus influenzae type b conjugate and diphtheria-tetanus- pertussis containing acellular pertussis. Lancet, 1999, 354 ( 9195 ) :2063-2068.
  • 8Carlsson RM, Claesson BA, Fagerlund E, et al. Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy. Pediatr Infect Dis J, 2002, 21 (6) :535-541.
  • 9Li RC, Li FX, Li YP, et al. Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China. Vaccine, 2011, 29 (10) : 1913-1920.
  • 10Li RC, Li FX, Li YP, et al. Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP ~ T vaccine compared to separate vaccines ( DTaP, PRP - T and IPV) following primary vaccination of healthy infants in the People' s Republic of China. Vaccine, 2011, 29(50) :9337-9344.

共引文献26

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部